ANGELA WHITTLE-MERCHANT: Open Payments
NPI 1962549899 · SUMTER, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$410 in 17 payments from 12 companies in 2025. Trend: 2023 $36 · 2024 $273 · 2025 $410
Food & beverage: $410
| Company | Payments | Amount |
|---|---|---|
| PharmaEssentia USA Corporation | 3 | $89 |
| Merck Sharp & Dohme LLC | 3 | $80 |
| Astellas Pharma US Inc | 1 | $32 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
| Lilly USA, LLC | 1 | $29 |
| SOBI, INC | 1 | $26 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Incyte Corporation | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
Products named: BESREMI, KEYTRUDA, Xtandi, KISQALI, VERZENIO, Doptelet, Orserdu, JAKAFI.
Industry payments across SC — which companies pay providers there.
